Microbial identification or identification of microorganisms such as harmful bacteria and fungi plays a central role in the quality control (QC) microbiology lab. Identification measures of microbes include – microscopy and specimen biochemical test. The ability to identify exactly which microorganism strain is present in a sample is a fundamental need of almost all microbiologists. These rapid molecular techniques are now replacing traditional culture-based methods.
According to a research report published in Markets and Markets, this microbial identification market is estimated at $896.5 million in 2014 and is expected to reach $1,194.1 million by 2019, growing at a CAGR of 5.9% from 2014 to 2019. The research report is titled “Microbial Identification Market by Products (Consumables, Instruments, Services), Methods (Phenotypic, Genotypic), Application (Pharmaceutical, Diagnostic, Environmental, Food & Beverages) & by End User (Detection, Characterization) – Global Forecasts to 2019”.
Factors that contribute to the growth of this market are:
- Technological advancements
- High prevalence of infectious diseases
- Growing food safety concerns
- Government initiatives
- Higher healthcare expenditure in the emerging geographies
End users for microbial characterization are government/private institutes, hospitals, and diagnostic laboratories, pharmaceutical and biotechnology companies, and CROs and independent research laboratories.
The prominent players in the microbial identification market include – Becton, Dickinson and Company, (U.S.), bioMérieux SA (France), Bruker Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Siemens healthcare (Germany).
Geographically, North America dominates the market, followed by Europe, Asia-pacific and the Rest of the World (ROW).